These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 4398920)
21. [Some pharmacologic properties of a new compound blocking the autonomic ganglia]. Filczewski M; Malecki I; Ernest K; Oledzka K Acta Physiol Pol; 1966; 17(3):525-34. PubMed ID: 4381328 [No Abstract] [Full Text] [Related]
22. Effect of some monoamine oxidase inhibitors on reflex pressor and nictitating membrane responses. Bose D; Bhagwat AW; Agarwal SL Indian J Med Res; 1967 Aug; 55(8):884-8. PubMed ID: 5598205 [No Abstract] [Full Text] [Related]
23. [Studies on the mechanism of the hypotensive action of monoaminoxidase inhibitors]. Gawecka I; Gumulka W Acta Physiol Pol; 1965; 16(4):567-77. PubMed ID: 4223825 [No Abstract] [Full Text] [Related]
24. [On the pharmacology of N-(2-guanidinoethyl)-4-methyl-1,2,3,6-tetrahydropyridine, a new antihypertensive-acting compound]. Kroneberg G; Schlossmann K; Stoepel K Arzneimittelforschung; 1967 Feb; 17(2):199-207. PubMed ID: 5631784 [No Abstract] [Full Text] [Related]
25. Cardiovascular effects of a new antihypertensive agent in several species. Salvati P; Caravaggi AM; Lamberti E; Monteggia M; Bianchi G Arzneimittelforschung; 1983; 33(8):1098-106. PubMed ID: 6685486 [TBL] [Abstract][Full Text] [Related]
26. [On the mechanism of toxic effect of triethylamine]. Chernen'kiĭ IK Farmakol Toksikol; 1968; 31(6):750-2. PubMed ID: 4388891 [No Abstract] [Full Text] [Related]
27. The role of bioactivation on the pharmacology of the potent monoamine oxidase inhibitor 5-oxo-N-(D-trans-2-phenylcyclopropyl)-L-2-pyrrolidine-carboxamide (EX-4883). Lowe MC; Horita A Proc West Pharmacol Soc; 1969; 12():87. PubMed ID: 5812307 [No Abstract] [Full Text] [Related]
28. [On the pharmacology of quaternary derivatives of beta-phenylethylamine]. Holtz P; Menkens K; Palm D Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(2):193-220. PubMed ID: 4385671 [No Abstract] [Full Text] [Related]
29. Pharmacology and mechanism of action of cryptenamine. Jandhyala BS; Buckley JP J Pharm Sci; 1966 Sep; 55(9):888-93. PubMed ID: 5918523 [No Abstract] [Full Text] [Related]
30. Experimental observations on the effects of adrenaline after treatment with antidepressant monoamine oxidase inhibitor (MAOI) drugs. Trinker FR; Fearn H; McCulloch MW; Rand MJ Aust Dent J; 1967 Aug; 12(4):297-303. PubMed ID: 5233628 [No Abstract] [Full Text] [Related]
31. Pharmacological properties of heterocyclic amidine derivatives. II. Pharmacological studies of phenylguanylpiperazine derivatives. Ozawa H; Iwatsuki K Chem Pharm Bull (Tokyo); 1968 Dec; 16(12):2482-7. PubMed ID: 5719030 [No Abstract] [Full Text] [Related]
32. Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat. Finberg JP; Youdim MB Br J Pharmacol; 1985 Jun; 85(2):541-6. PubMed ID: 3928010 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological studies with some new antihypertensive aminoquinazolines. Scriabine A; Constantine JW; Hess HJ; McShane WK Experientia; 1968 Nov; 24(11):1150-1. PubMed ID: 5721146 [No Abstract] [Full Text] [Related]